Ticker Symbol: ONTX
Onconova Therapeutics Inc
$3.34 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001130598
Company Profile
Onconova Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 375 Pheasant Run
Website: www.onconova.com
CEO: Steven Fruchtman
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.67
Change:
$0.00
(
-0.45%)
Days Range: $0.55 - $0.76
Beta: 0.54
52wk. High: $1.49
52wk. Low: $0.55
Ytd. Change 3.33%
50 Day Moving Average: $0.73
200 Day Moving Average: $0.96
Shares Outstanding: 20977625
Valuation
Market Cap: 1.4B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A